(702) 683-8946

Monday - Friday 9am to 5pm



Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)



CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business


Latest News Releases From The Newsroom

1847 Seeks Strategic Alternatives; Bullish Stance On L3Harris

September 18th, 2023

Shares of 1847 Holdings LLC (NYSE American: EFSH) surged by more than 5% in pre-market trading following the company's announcement of engaging Spartan Capital Securities LLC to explore strategic alternatives geared towards boosting shareholder value. Read more

FedEx, General Mills, and KB Home's Earnings Preview: Key Metrics

September 17th, 2023

On Wednesday, September 20, a lineup of companies is slated to announce their financial results, including: FedEx Corp. (NYSE: FDX), a global courier giant, is set to unveil its first-quarter fiscal 2024 financial results after the market's closin. Read more

Earnings in Focus: AutoZone, Endava , and Apogee Enterprises Gear Up

September 16th, 2023

On Tuesday, September 19, several companies are scheduled to announce their financial results, including: AutoZone, Inc. (NYSE: AZO), a leading auto parts retailer, is set to announce fourth-quarter results for the period ending August 26, 2023, b. Read more

President Biden: Auto Workers Deserve Fair Compensation

September 15th, 2023

President Joe Biden addressed the ongoing auto strike and contract negotiations between the United Auto Workers (UAW) and the Big 3 auto companies: Ford Motor Company (NYSE: F), General Motors Company (NYSE: GM), and Stellantis N.V. (NYSE: STLA). He . Read more

PDUFA Extension Fuels Iovance Biotherapeutics; PTC Therapeutics Faces Setback

September 15th, 2023

Shares of Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) surged over 10% after the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) for lifileucel due to resource constraints. The new target action date is . Read more

Earnings Reaction Wave: Adobe Dips, eGain Climbs

September 14th, 2023

Adobe Inc. (Nasdaq: ADBE), a prominent software company, reported robust third-quarter fiscal 2023 earnings, with an EPS of $4.09, surpassing the consensus EPS estimate of $3.98. The company's quarterly sales reached $4.89 billion, slightly above ana. Read more

Breaking News: AMC's $325.5M Equity Raise and Draganfly's Defense Orders

September 14th, 2023

AMC Entertainment Holdings, Inc. (NYSE: AMC) said that it successfully raised approximately $325.5 million in new equity capital by selling 40 million shares at an average price of around $8.14 per share, before commissions and fees. $AMC was trad. Read more

Redburn Partners: Carnival and Norwegian Cruise Line are a Buy

September 14th, 2023

Carnival Corporation & plc (NYSE: CCL), a leading cruise line company, has been upgraded by Redburn Partners from Neutral to Buy, along with a price target of $23. With $CCL closing at $15.02 on Wednesday, this price target suggests a potential up. Read more

Semtech Posts Upbeat Results, Outlook Falls Short; FDA Panel Backs Alnylam's Patisiran

September 13th, 2023

Semtech Corporation (Nasdaq: SMTC), a technology company specializing in semiconductor solutions, reported earnings of $0.11 per share for the second quarter of fiscal 2024, surpassing the consensus EPS estimate of $0.02. Quarterly sales for Semtech . Read more

IBEX Misses Estimates, Guides Revenue Below-Consensus

September 13th, 2023

IBEX Limited (Nasdaq: IBEX), a company specializing in customer support solutions, reported earnings of $0.33 per share for the fourth quarter of fiscal 2023. This figure fell short of the consensus EPS estimate of $0.49. Quarterly sales for IBEX amo. Read more